REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exo (pronounced “echo”), a pioneering health information and devices company, closed a $40 million Series B+ funding round that will fund research and product ...

Exo, a developer of new diagnostic hardware for the medical industry, has raised $40 million in a new round of funding as investors continue to back new companies that are reducing the cost and ...

The U.S. Food & Drug Administration has granted breakthrough device designation for an exo-suit helping people with neurological-injury-related ankle issues walk, according to ReWalk Robotics, Ltd. of ...

Exo (pronounced “echo”) is on a mission to make the ultrasound machine as easy to use as a smartphone camera. To do that, the company has developed a software platform called Exo Works, which is ...

Exo, pronounced “echo,” raised a fresh cash infusion of $220 million in Series C financing aimed at commercializing its handheld ultrasound device and point-of-care workflow platform, Exo Works. The ...

July 29(Reuters) - Handheld ultrasound device maker Exo said on Thursday it had raised $220 million in a funding round led by health and life sciences investor RA Capital Management. The company did ...